Key result
Microalbuminuria affects ~39% of T2D patients, rising significantly with longer disease duration.
Why the study?
Monitoring microalbuminuria and associated risk factors in type 2 diabetes patients is important to prevent or postpone overt nephropathy, but prevalence data in Tirana were lacking.
Cross-Sectional (n=220)
Yes
Alerts clinicians to high microalbuminuria burden after 16 years of T2D; leaves open generalizability and need for prospective validation.
No takes yet. Share an insight, caveat, or question.
Pasko et al. (2013) conducted a cross-sectional in Type 2 diabetes (n=220). Type 2 diabetes was evaluated on Prevalence of microalbuminuria. Type 2 diabetes patients in Tirana had a 38.6% prevalence of microalbuminuria, with the risk significantly increasing 16 years after diagnosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: